Growing trend of personalized medicine is a key factor projected to support growth of proteomics market.
Market Size – USD 19.37 Billion in
2019, Market Growth - CAGR of 14.5%, Market Trends – Advancements in
technology.
The Global Proteomics Market Is expected to reach a market size of USD 57.57 Billion by
2027 and register a high CAGR during the forecast period, according to a new
report by Reports and Data.
The proteomics market is witnessing increased revenue growth due to the growing popularity of personalized medicines, advancements in technology, and rise in research & development expenditure and initiatives. A key driving factor is the rising trend of personalized medicine. Biotechnology and pharmaceutical companies have over the years doubled their investment in R&D of personalized medicine. Advancement in proteomics technologies contributed to the development of personalized medicines by enabling detection of proteomics molecular diagnostics, protein biomarkers, pharmacoproteomics, and protein biochips. Personalized medicine is commonly used in cancer treatment.
High cost of proteomics equipment and
lack of skilled workforce is a factor hampering growth of the market. However,
growth in biomarker identification and advancements in mass spectrometry-based
proteomics are expected to provide growth opportunities in the proteomics
market. Development of efficient and advanced technologies, rise in genetic and
birth disorders, increasing healthcare expenditure, and availability of funds
from both public and private sectors will contribute significantly to growth of
the market.
Ask for
Sample Report @ https://www.reportsanddata.com/sample-enquiry-form/3769
The COVID-19 impact:
The COVID-19 pandemic has spurred
growth of the proteomics market. Biopharmaceutical companies are investing
significantly in research for the development of SARS-COV-2 vaccine.
Researchers are identifying drugs for treatments by using separation and
identification techniques to examine both new and existing drugs, which is
driving growth of the proteomics market.
Further key findings in the report
·
The reagent segment among the product
segments accounted for the largest revenue share in 2019. Increasing research
activities and growing need for protein separation from complex mixtures for
effective analysis is expected to continue to drive revenue growth of this segment.
·
Microarray segment dominated other
technology segments in terms of revenue share in 2019. Microarray offers
label-free detection, full imprint of proteins, and produces vast amounts of
information from small samples, which is driving demand for application in
biopharmaceutical companies.
·
The drug discovery segment revenue is
expected to continue to register a robust growth rate due to increasing
application of proteomics in identification of toxicity and efficacy from
biological fluids and target validation and identification. Identification of
new drugs by proteomics is one of the major factors supporting market growth.
·
North America accounted for the
largest share in the global proteomics market in 2019. Increasing research
activities in healthcare, high funding from governments, and rising need for
improved healthcare infrastructure are some key factors driving growth of the
market.
·
Key participants include Agilent Technologies, Inc., Danaher
Corporation, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Merck
KgaA, PerkinElmer, Inc., Promega Corporation, Waters Corporation, Bruker
Corporation, and GE Healthcare.
Request a customization of the report @
https://www.reportsanddata.com/request-customization-form/3769
For the purpose of this report,
Reports and Data has segmented the global proteomics market on the basis of
product, technology, application, and region:
Product Outlook (Revenue, USD
Billion; 2017-2027)
·
Instruments
·
Reagents
·
Services
Technology Outlook (Revenue, USD
Billion; 2017-2027)
·
X-Ray Crystallography
·
Chromatography
·
Microarray Instruments
·
Protein Fractionation Systems
·
Surface Plasma Resonance (SPR)
Systems
·
Electrophoresis
·
Spectroscopy
Application Outlook (Revenue, USD
Billion; 2017-2027)
·
Clinical Diagnosis
·
Drug Discovery
·
Others
Regional Outlook (Revenue, USD
Billion; 2017-2027)
·
North America
o
U.S
o
Canada
·
Europe
o
Germany
o
U.K
o
France
o
BENELUX
o
Rest of Europe
·
Asia Pacific
o
China
o
Japan
o
South Korea
o
Rest of APAC
·
MEA
o
Saudi Arabia
o
UAE
o
Rest of MEA
·
Latin America
o
Brazil
o
Rest of LATAM
To know more about the report @ https://www.reportsanddata.com/report-detail/proteomics-market
Some
major points covered in this Proteomics Market report:
1. An excessively meticulous
study that helps in segmenting the useful data from the irrelevant.
2. The study has been segmented and sub-segmented into regions, end-users,
applications, product types, players according to the influence they exercise
in the Proteomics market, their strategies, and the potential consumer bases
that a new entrant can tap into.
3. In the next section, factors
responsible for the growth of the market have been included. This data has been
collected from the primary and secondary sources and has been approved by the
industry specialists. It helps in understanding the key market segments and
their future trends.
4. The participants of this
industry who possess and employ influence over the Proteomics market are
highlighted in the study and their respective strategies to overcome the
competition and challenges of the eco-system they perform in.
5. The Proteomics market
research report also presents an eight-year forecast on the basis of how the
market is predicted to grow.
Table of Content:
Chapter 1. Market Synopsis
1.1. Market
Definition
1.2. Research Scope
& Premise
1.3. Methodology
1.4. Market
Estimation Technique
Chapter 2. Executive Summary
2.1. Summary
Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Proteomics Market Segmentation &
Impact Analysis
4.1. Proteomics
Market Material Segmentation Analysis
4.2. Industrial
Outlook
4.2.1.
Market indicators analysis
4.2.2.
Market drivers analysis
4.2.2.1. increasing pharmaceutical and
biotechnology R&D expenditure and government funding for proteomics
4.2.2.2. increasing demand for personalized medicine
4.2.3.
Market restraints analysis
4.2.3.1. High cost of instruments
4.3. Technological
Insights
4.4. Regulatory
Framework
4.5. ETOP Analysis
4.6. Porter’s Five
Forces Analysis
4.7. Competitive
Metric Space Analysis
4.8. Price trend
Analysis
4.9. Customer Mapping
4.10. Covid-19 Impact
Analysis
4.11. Global
Recession Influence
Chapter 5. Proteomics Market By Product Insights
& Trends
Continued….
Thank you for reading our report.
Customization of the report is available based on the client’s requirements.
For more details, kindly connect with us, and our team will ensure the report
is suited to meet your requirements.
Browse More Reports:
Oncology
Information System Market Share
About Us:
Reports
and Data is a market research and consulting company that provides syndicated
research reports, customized research reports, and consulting services. Our
solutions purely focus on your purpose to locate, target and analyze consumer
behavior shifts across demographics, across industries and help client’s make a
smarter business decision. We offer market intelligence studies ensuring
relevant and fact-based research across a multiple industries including
Healthcare, Technology, Chemicals, Power and Energy. We consistently update our
research offerings to ensure our clients are aware about the latest trends
existent in the market.
Contact Us:
John W
Head of Business Development
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com
News: www.reportsanddata.com/market-news
Connect with us: Facebook | LinkedIn | Twitter
No comments:
Post a Comment